NCT07356817 · RECRUITING

Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications

This study is tracking about 1,800 women who had a pregnancy 3 to 6 years ago, some of whom had complications like preeclampsia. Researchers are measuring their current cardiovascular health and trying to build a risk-prediction tool, ideally a mobile app, that accounts for pregnancy history and environmental factors. The phase is unspecified, and this is an observational study, not a drug or treatment trial.

You may qualify if

  • Patients who participated in the BiSC (Barcelona Life Study Cohort), EuroPE (Randomized open-label control trial to evaluate if the incorporation of sFlt1/PlGF ratio in the diagnosis and classification of PE improves maternal and perinatal outcomes in women with suspicion of the disease; PI16/00375) and AngioCor (Cardiac dysfunction and remodeling in patients with preeclampsia regulated by antiangiogenic environment: clinical and experimental approach, PI19/00702) cohort studies
  • Who have delivered within the previous 3-6 years.
  • Give written consent when invited to participate in this study protocol.

You're excluded if

  • Unwillingness to participate in this study
  • Probability of loss to follow-up.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-01-21

View full record on ClinicalTrials.gov

All APOE4 clinical trials